Clinical Trial Update: Vaginal Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy in Primarily Infertile Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating vaginal isoniazacid hydrazide before diagnostic hysteroscopy in primarily infertile female patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility Female

Drugs mentioned

• Vaginal Isonicotinic Acid Hydrazide (isonicotinic acid hydrazide (pyridinecarboxamide derivative))

Snippet

Sponsor: Aswan University Hospital | Conditions: Infertility, Female | Phase 4 | Status: COMPLETED